Tumor Implantation
Tumor Implantation - Related Videos
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
10:52
Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
0 Views •
Cited by 42 •
2012
We describe an integrated method for the precise, stereotactic implantation of human glioblastoma multiforme cells into the brains of nude mice and subsequent serial in vivo imaging to monitor growth and response to treatment of the resultant xenografts.
05:08
Fluorescent Orthotopic Mouse Model: Implanting GFP Expressing Cancer Cells into Mouse for Assessing Tumor Progression In Vivo
0 Views •
2023
This video demonstrates the protocol for implanting green fluorescent protein-expressing pancreatic cancer cells orthotopically into the pancreas of the mouse. The orthotopic mouse model helps in investigating the efficacy of novel therapeutics on primary and metastatic tumors.
05:06
Fluorescence-guided Tumor Resection and MSC-seeded Scaffold Implantation in Murine Model: A Surgical Procedure to Deliver Therapeutic Mesenchymal Stem Cells into Brain Tumor Resection Cavity in Mouse Model
0 Views •
2025
This video presents the surgical procedure for image-guided tumor resection and implantation of a bio-scaffold seeded with genetically engineered mesenchymal stem cells or MSCs expressing tumor necrosis factor-related apoptosis-inducing ligand or TRAIL. These therapeutic MSCs have the potential in treatment of brain tumors.
04:48
Intracranial Cannular Implantation in a Mouse to Deliver Therapeutic Agents to Brain Tumors
0 Views •
2025
This video presents a procedure for intracranial cannula implantation in a brain tumor mouse model, to facilitate the administration of an immunotherapeutic agent. The delivery of glypican-2-specific chimeric antigen receptor T cells in the tumor microenvironment triggers T cell activation, resulting in tumor lysis and tumor regression.
FAQs
A newly implanted tumor cannot depend only on the surrounding tissue for continued growth. It must recruit blood vessels to support increasing cellular demands. This vascular interaction is therefore a key transition between initial survival and the development of a measurable tumor. Studying it helps biology researchers examine how tumor-host interactions influence progression and potential treatment responses.
The anatomical site affects how implanted tumor cells interact with nearby tissues and the local microenvironment. Because those surroundings can influence growth and behavior, tumors placed at different sites may provide different biological information. Comparing implantation locations allows investigators to assess how tissue context contributes to tumor development, invasion, and responses observed in experimental models.
Implanted cells must first survive in the host and attach to surrounding tissue. They then interact with the local microenvironment and recruit blood vessels as the tumor develops. These sequential requirements explain why implantation alone does not guarantee immediate tumor formation. Monitoring the resulting growth provides a way to study the biological steps connecting cellular placement with measurable disease.
Subcutaneous models place tumor cells or tissue beneath the skin, whereas orthotopic models use a site corresponding to the tumor’s tissue of origin. The two approaches provide different experimental contexts because anatomical location influences growth and behavior. Researchers can select between them according to whether they need a general implantation model or want to examine tumor-host interactions in a more tissue-specific setting.
A controlled study begins by placing tumor cells or tissue into a selected host site, followed by observation of whether the implanted material survives, attaches, and develops. Investigators then monitor tumor formation as a measurable outcome. The chosen anatomical location and model type are recorded because they help determine how growth, invasion, and treatment responses should be interpreted.
These models are useful when investigators need to examine tumor development, invasion, metastasis, or responses to anticancer treatments in a host context. Controlled placement provides a defined experimental starting point, while natural spread can represent another route of tumor establishment. Together, these approaches support analysis of tumor-host interactions and the evaluation of potential therapeutic strategies.